By all predictions, 2010 has the opportunity to be a strong rebound year for the Life Sciences industry. The buzz is beginning to grow on the number of financing opportunities, including both asset and cash flow lending, venture debt, and mezzanine financing. We continue to hear about increased volume of M & A activity as well as increasing numbers of companies beginning the IPO process. Join us as we take a look at some recent deals and share some predictions on future deal trends in 2010 REGISTER HERE